A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus
- PMID: 11689882
- DOI: 10.1038/nm1101-1189
A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus
Abstract
In systemic lupus erythematosus, antibodies against double-stranded DNA are a major contributor to renal disease. We have previously demonstrated that the pentapeptide Asp/Glu-Trp-Asp/Glu-Tyr-Ser/Gly is a molecular mimic of double-stranded DNA. This sequence is also present in the extracellular domain of murine and human NMDA (N-methyl-D-aspartate) receptor subunits NR2a and NR2b. Here we show that the NR2 receptor is recognized by both murine and human anti-DNA antibodies. Moreover, anti-DNA antibodies with this cross-reactivity mediate apoptotic death of neurons in vivo and in vitro. Finally, we show that the cerebrospinal fluid of a patient with systemic lupus erythematosus contains these antibodies and also mediates neuronal death via an apoptotic pathway. These observations indicate that lupus antibodies cross-react with DNA and NMDA receptors, gain access to cerebrospinal fluid and may mediate non-thrombotic and non-vasculitic abnormalities of the central nervous system.
Comment in
-
Anti-DNA meets NMDA in neuropsychiatric lupus.Nat Med. 2001 Nov;7(11):1175-6. doi: 10.1038/nm1101-1175. Nat Med. 2001. PMID: 11689873 No abstract available.
Similar articles
-
Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.Int J Rheum Dis. 2019 Mar;22(3):443-448. doi: 10.1111/1756-185X.13392. Epub 2018 Oct 24. Int J Rheum Dis. 2019. PMID: 30358102
-
Anti-DNA meets NMDA in neuropsychiatric lupus.Nat Med. 2001 Nov;7(11):1175-6. doi: 10.1038/nm1101-1175. Nat Med. 2001. PMID: 11689873 No abstract available.
-
Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19854-9. doi: 10.1073/pnas.0608397104. Epub 2006 Dec 14. Proc Natl Acad Sci U S A. 2006. PMID: 17170137 Free PMC article.
-
[Anti-NMDA receptor antibody in systemic lupus erythematosus].Nihon Shinkei Seishin Yakurigaku Zasshi. 2013 Nov;33(5-6):225-30. Nihon Shinkei Seishin Yakurigaku Zasshi. 2013. PMID: 25069262 Review. Japanese.
-
Antibodies and the brain: anti-N-methyl-D-aspartate receptor antibody and the clinical effects in patients with systemic lupus erythematosus.Curr Opin Neurol. 2018 Jun;31(3):294-299. doi: 10.1097/WCO.0000000000000554. Curr Opin Neurol. 2018. PMID: 29474315 Review.
Cited by
-
Treatment with 1,25-Dihydroxyvitamin D3 Delays Choroid Plexus Infiltration and BCSFB Injury in MRL/lpr Mice Coinciding with Activation of the PPARγ/NF-κB/TNF-α Pathway and Suppression of TGF-β/Smad Signaling.Inflammation. 2023 Apr;46(2):556-572. doi: 10.1007/s10753-022-01755-5. Epub 2022 Oct 21. Inflammation. 2023. PMID: 36269513
-
Taming lupus-a new understanding of pathogenesis is leading to clinical advances.Nat Med. 2012 Jun 6;18(6):871-82. doi: 10.1038/nm.2752. Nat Med. 2012. PMID: 22674006 Free PMC article. Review.
-
Amending HIV Drugs: A Novel Small-Molecule Approach To Target Lupus Anti-DNA Antibodies.J Med Chem. 2016 Oct 13;59(19):8859-8867. doi: 10.1021/acs.jmedchem.6b00694. Epub 2016 Sep 20. J Med Chem. 2016. PMID: 27603688 Free PMC article.
-
Anti-N-Methyl-D-Aspartate Receptor Encephalitis in a Patient with Systemic Lupus Erythematosus.J Clin Neurol. 2016 Oct;12(4):502-504. doi: 10.3988/jcn.2016.12.4.502. J Clin Neurol. 2016. PMID: 27819422 Free PMC article. No abstract available.
-
C5a alters blood-brain barrier integrity in experimental lupus.FASEB J. 2010 Jun;24(6):1682-8. doi: 10.1096/fj.09-138834. Epub 2010 Jan 11. FASEB J. 2010. PMID: 20065106 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical